Logo

BioEcho Life Sciences Gets CE-IVD Mark for Viral RNA/DNA Extraction Kit

May 10, 2021 | staff reporter

NEW YORK — BioEcho Life Sciences said on Monday that it has received CE-IVD marking for its EchoLution Viral RNA/DNA Swab Kit.

According to the German company, the kit enables the purification of viral RNA, including SARS-CoV-2 RNA, in five minutes and is compatible with commonly available transport media.

BioEcho, based in Cologne, was founded in 2016 by former Qiagen employees to commercialize a sample prep technology, dubbed reverse chromatography-based nucleic acid purification, in which the separation matrix binds everything except the nucleic acid. The firm had originally been using the technology only for DNA purification but developed an RNA extraction protocol for use with COVID-19 samples when the SARS-CoV-2 pandemic hit Germany.

Filed under

Molecular Diagnostics
Infectious Disease
Regulatory News & FDA Approvals
Business News
Sample Preparation
CE mark
Europe
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.